These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23049444)

  • 1. Plasminogen and fibrinogen plasma levels in coronary artery disease.
    Lima LM; Carvalho Md; Sousa Mde O
    Rev Bras Hematol Hemoter; 2012; 34(4):298-301. PubMed ID: 23049444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired fibrinolysis in angiographically documented coronary artery disease.
    Fernandes AB; Lima LM; Sousa MO; Toledo Vde P; Kazmi RS; Lwaleed BA; Carvalho Md
    Adv Hematol; 2015; 2015():214680. PubMed ID: 25810721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-dimer plasma levels in NSTE-ACS patient.
    Charoensri N; Pornratanarangsi S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S39-45. PubMed ID: 21721427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity of coronary artery disease and basal fibrinolysis.
    Small M; Lowe GD; Beattie JM; Hutton I; Lorimer AR; Forbes CD
    Haemostasis; 1987; 17(5):305-11. PubMed ID: 2444504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dehydroepiandrosterone therapy in men with angiographically verified coronary heart disease: the effects on plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA) and fibrinogen plasma concentrations].
    Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2007; 58(3):213-9. PubMed ID: 17940987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAI-1 4G/5G polymorphism and plasma levels association in patients with coronary artery disease.
    Lima LM; Carvalho Md; Fonseca Neto CP; Garcia JC; Sousa MO
    Arq Bras Cardiol; 2011 Dec; 97(6):462-389. PubMed ID: 22011808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial).
    McBane RD; Hardison RM; Sobel BE;
    Am J Cardiol; 2010 Jan; 105(1):17-24. PubMed ID: 20102884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in coagulation and fibrinolysis in subjects with coronary artery disease.
    Ossei-Gerning N; Wilson IJ; Grant PJ
    Thromb Haemost; 1998 Apr; 79(4):736-40. PubMed ID: 9569183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease.
    Olofsson BO; Dahlén G; Nilsson TK
    Eur Heart J; 1989 Jan; 10(1):77-82. PubMed ID: 2495219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired fibrinolysis in coronary artery disease.
    Francis RB; Kawanishi D; Baruch T; Mahrer P; Rahimtoola S; Feinstein DI
    Am Heart J; 1988 Apr; 115(4):776-80. PubMed ID: 3128096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 Diabetes and Cardiovascular Factors Contrasted with Fibrinolysis Disorders in the Blood of Patients with Peripheral Arterial Disease.
    Wieczór R; Wieczór AM; Kulwas A; Rość D
    Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31336615
    [No Abstract]   [Full Text] [Related]  

  • 12. D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction.
    Tataru MC; Heinrich J; Junker R; Schulte H; von Eckardstein A; Assmann G; Koehler E
    Eur Heart J; 1999 Oct; 20(20):1493-502. PubMed ID: 10493848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of tissue plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen with coronary artery disease in South Indian male subjects.
    Deepa R; Velmurugan K; Saravanan G; Dwarakanath V; Agarwal S; Mohan V
    J Assoc Physicians India; 2002 Jul; 50():901-6. PubMed ID: 12126344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen in relation to degree and composition of coronary plaque on intravascular ultrasound in patients undergoing coronary angiography.
    Buljubasic N; Akkerhuis KM; Cheng JM; Oemrawsingh RM; Garcia-Garcia HM; de Boer SP; Regar E; van Geuns RM; Serruys PW; Boersma E; Kardys I
    Coron Artery Dis; 2017 Jan; 28(1):23-32. PubMed ID: 27755007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the fibrinolytic system in patients with coronary artery disease and hyperfibrinogenemia.
    Stein D; Heins M; Schoebel FC; Pels K; Jax TW; Stiegler H; Reinauer H; Strauer BE; Leschke M
    Thromb Haemost; 1997 May; 77(5):970-4. PubMed ID: 9184412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum levels of lipoprotein(a) correlated with the severity of coronary artery disease in patients submitted to angiography.
    Lima LM; Carvalho Md; Loures-Vale AA; Fernandes AP; Mota AP; Neto CP; Garcia JC; Saad JA; Souza Mde O
    Arq Bras Cardiol; 2006 Sep; 87(3):260-6. PubMed ID: 17057924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are correlated with the presence of transplant coronary artery disease in cardiac transplant recipients.
    Warshofsky MK; Wasserman HS; Wang W; Teng P; Sciacca R; Apfelbaum M; Schwartz A; Michler RE; Mancini DM; Cannon PJ; Rabbani LE
    Am J Cardiol; 1997 Jul; 80(2):145-9. PubMed ID: 9230149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue plasminogen activator activity and inhibition in acute myocardial infarction and angiographically normal coronary arteries.
    Verheugt FW; ten Cate JW; Sturk A; Imandt L; Verhorst PM; van Eenige MJ; Verwey W; Roos JP
    Am J Cardiol; 1987 May; 59(12):1075-9. PubMed ID: 3107367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of Plasma Fibrinogen Level With the Presence, Severity, and Complexity of Coronary Artery Disease.
    Tabakcı MM; Gerin F; Sunbul M; Toprak C; Durmuş Hİ; Demir S; Arslantaş U; Cerşit S; Batgerel U; Kargın R
    Clin Appl Thromb Hemost; 2017 Sep; 23(6):638-644. PubMed ID: 26865586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretory phospholipase A2 in patients with coronary artery disease.
    Lima LM; Carvalho Md; da Fonseca Neto CP; Garcia JC; Sousa MO
    J Thromb Thrombolysis; 2010 Apr; 29(3):276-81. PubMed ID: 19449149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.